Intraoperative radiation therapy: Is it a standard now?

Breast

Volumn 20, Issue SUPPL. 3, 2011, Pages

  Orecchia, Roberto ^a,b   Leonardo, Maria Cristina ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast cancer; Intraoperative radiotherapy; Partial breast irradiation

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONSENSUS; DNA MICROARRAY; EUROPE; FOLLOW UP; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE RADIOTHERAPY; MEDICAL SOCIETY; META ANALYSIS (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL BREAST IRRADIATION; PATIENT SAFETY; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHENOTYPE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RISK ASSESSMENT; SAMPLE SIZE; SEGMENTAL MASTECTOMY; UNITED STATES; WHOLE BREAST RADIOTHERAPY;

EID: 80054855385     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/S0960-9776(11)70307-1     Document Type: Article

References (37)

1. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N EnglJ Med 2002, 347:1227-1232.
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. NEnglJ Med 2002, 347:1233-1241.
3. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
4. Orecchia R, Ivaldi GB, Leonardi MC Integrated breast conservation and intraoperative radiotherapy. Breast 2009, 18(Suppl 3):S98-S102.
5. Nairz O, Deutschmann H, Kopp M, et al. A dosimetric comparison of IORT techniques in limited-stage breast cancer. Strahlenther Onkol 2006, 182:342-348.
6. Kirkpatrick JP, Meyer JJ, Marks LB The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 2008, 18:240-243.
7. Brenner DJ The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 2008, 18:234-239.
8. Rosenstein B, Lymberis S, Formenti S Biologic comparison of partial breast irradiation protocols. IntJ Radiat Oncol Biol Phys 2004, 60:1393-1404.
9. Vaidya JS, Joseph DJ, Tobias JS, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 2010, 376:91-102.
10. Holland R, Veling SH, Mravunac M, et al. Histologic multifocality of Tis, Tl-2 breast carcinoma. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56:979-990.
11. Veronesi U, Orecchia R, Luini A, et al. Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat 2010, 124:141-151.
12. Smith TE, Lee D, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses and therapeutic management. Int J Radiat Oncol Biol Phys 2000, 48:1281-1289.
13. Kaufmann M, Morrow M, von Minckwitz G, et al. Locoregional treatment of primary breast cancer. Consensus Recommendations from an International Expert Panel. Cancer 2010, 116:1184-1191.
14. Sautter-Bihl ML, Budach W, Dunst J, et al. DEGRO Practical Guidelines for Radiotherapy of Breast Cancer I. Breast-conserving therapy. Strahlenther Onkol 2007, 183:661-666.
15. Goldhirsch A, Ingle JB, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009, 20:1319-1329.
16. NCC guidelines http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf.
17. Smith BD, Arthur DW, Bucholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). IntJ Radiat Oncol Biol Phys 2009, 74:987-1000.
18. Polgar C, Van Limbergen E, Potter R, et al. Patient selection for accelerated partial breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapy-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence 2009. Radiother Oncol 2010, 94:264-273.
19. Shaitelman SF, Vicini FA, Beitsch P, et al. Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation. Cancer 2010, 116:4677-4685.
20. Jones HA, Antonini N, Hart AAM, et al. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol 2009, 27:4939-4947.
21. Wildiers H, Biganzoli L, Fracheboud J, et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007, 8:1101-1115.
22. Hughes KS, Schnaper LA, Cirrincione C, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer. J Clin Oncol 2010, 28:15s. (abstract 507).
23. Williams LJ, Kunkler IH, King CC, et al. A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of Life at 5 years in the PRIME trial. Health Tech Assess 2011, 15:1-64.
24. Lemanski C, Azria D, Gourgon-Bourgade S, et al. Intraoperative radiotherapy in early stage breast cancer: results of the Montpellier phase II trial. Int J Radiat Oncol Biol Phys 2010, 76:698-703.
25. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinoma distinguish tumor subclasses with clinical implications. ProcNatl Acad Sci USA 2001, 98:10869-10874.
26. Wilder RB, Curcio LD, Khanjou RK, et al. Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status. IntJ Radiat Oncol Biol Phys 2010, 78:799-803.
27. Freedman GM, Anderson PR, Li T, et al. Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer 2009, 115:946-951.
28. Gabos Z, Thorns J, Ghosh S, et al. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Breast Cancer Res Treat 2010, 124:187-194.
29. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008, 26:3248-3258.
30. Al-Hallaq HA, Mell LK, Bradely JA, et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer 2008, 113:2408-2414.
31. Tendulkar RD, Chellman-Jeffers M, Rybicki LA, et al. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer 2009, 115:1621-1630.
32. Godinez J, Gombos EC, Chikarmane SA, et al. Breast MRI in the evaluation of eligibility for accelerated partial breast irradiation. Am J Roentgenol 2008, 191:272-277.
33. Valachis A, Mauri D, Polyzos NP, et al. Partial breast irradiation or whole breast radiotherapy for early breast cancer: a metanalysis of randomized controlled trials. BreastJ 2010, 16:245-251.
34. Antonini N, Jones H, Horiot JC, et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 2007, 82:265-271.
35. Ott OJ, Hildebrandt G, Potter R, et al. Accelerated partial breast irradiation with interstitial implants: risk factors associated with increased local recurrence. Int J Radiat Oncol Biol Phys 2010, in press.
36. http://www.rtog.org/ClinicalTrials/ProtocolTable.aspx.
37. Patel RR, Christensen ME, Hodge CW, et al. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results. Int J Radiat Oncol Biol Phys 2008, 70:970-973.